LDN Social Media
Get connected with us on social networks
Addressing the inflammatory impact of psoriasis - Apple Bodemer, MD (2021 Conference) (LDN, low dose naltrexone)
Psoriasis is a chronic systemic inflammatory condition with clinically important comorbidities. Dr. Bodemer discusses the common clinical picture of psoriasis, the comorbidities associated with psoriasis, and some of the inflammatory markers that are associated with psoriasis and psoriatic comorbidities. She presents basic treatment options, including how low dose naltrexone (LDN) might impact the inflammation associated with both psoriasis and psoriatic comorbidities. Case studies are presented.
KEYWORDS: skin, psoriasis, arthritis, inflammatory markers, low dose naltrexone (LDN)
This is a summary of the presentation. Click on the video for full information.